Introduction NurExone (TSXV:NRX) an innovative Canadian biopharmaceutical company, has reached a significant milestone in its efforts to revolutionize spinal cord injury treatments. The company ...

An estimated 18,000 people in the United States annually suffer from new injuries to their spinal cords. Unfortunately for ...